Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) Other financing activities (2018 - 2022)

Updated

Chemomab Therapeutics' Other financing activities came in at $3.99 million for Q3 2023, down 34.7% from $6.12 million a year earlier.

Analysis

Chemomab Therapeutics (CMMB) Other financing activities (2018 - 2022) Analysis & Trends

Over the trailing twelve months to Sep 30, 2023, Chemomab Therapeutics reported Other financing activities of $11.22 million, up 104.4% year-over-year; for FY2018, it was -$641,000.

  • Going back by year, Other financing activities was $259,000 in FY2017 (+370.9%) and $55,000 in FY2016.
  • The Q3 2023 figure represents the lowest quarterly Other financing activities since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.42 Bn 1,106.00 Bn 19.71 Bn
2 Johnson & Johnson 617.98 Bn 536.51 Bn 17.26 Bn
3 AbbVie 502.80 Bn 475.92 Bn 12.70 Bn
4 Merck 368.67 Bn 323.05 Bn 12.21 Bn
5 Novartis Ag 298.36 Bn 262.35 Bn 11.24 Bn
6 Astrazeneca 261.17 Bn 234.85 Bn 12.86 Bn
7 Amgen 237.18 Bn 192.58 Bn 7.24 Bn
8 Gilead Sciences 191.11 Bn 165.31 Bn 6.22 Bn
9 Pfizer 169.83 Bn 116.48 Bn 10.94 Bn
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -1.22 Mn
Dec 31, 2021 -2.43 Mn
Mar 31, 2021 2.43 Mn
Dec 31, 2020 297,000.00
Jun 30, 2019 -1.20 Mn
Mar 31, 2019 -2.68 Mn
Dec 31, 2018 -543,000.00
Sep 30, 2018 -1.74 Mn
API Access

Chemomab Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CMMB&period=max&api_key=YOUR_API_KEY